Medical University Of Silesia Katowice Poland

The medical center is at the forefront of research into Tuberous Sclerosis Complex (TSC), a rare genetic disorder characterized by the growth of benign tumors in multiple organs. The center's research focuses on innovative therapies that address the neurological and behavioral challenges associated with TSC.

• Behavioral Outcomes
• Seizure Management
• Genetic Research

Through its pioneering studies, the center is enhancing the understanding of TSC and developing targeted treatments that improve the quality of life for patients and their families.

Specializing in Alzheimer's disease, the medical center is dedicated to advancing the treatment and understanding of this complex neurodegenerative disorder. The research conducted here aims to slow disease progression and improve cognitive functions in affected individuals.

• Cognitive Function Improvement
• Brain Atrophy Reduction
• Quality of Life Enhancement

By exploring novel therapeutic approaches, the center is making significant strides in the fight against Alzheimer's, offering hope for improved patient outcomes and enhanced daily living activities.